Activity and components of the granulocyte colony‐stimulating factor pathway in hidradenitis suppurativa*-Reference-Cited by-同舟云学术

Activity and components of the granulocyte colony‐stimulating factor pathway in hidradenitis suppurativa*

Published:2021-03-04 Issue:1 Volume:185 Page:164-176
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Wolk K.¹²^ORCID,Brembach T.‐C.¹³,Šimaitė D.⁴,Bartnik E.⁵,Cucinotta S.¹,Pokrywka A.⁶,Irmer M.L.¹,Triebus J.¹,Witte‐Händel E.¹,Salinas G.⁷,Leeuw T.⁵,Volk H.‐D.⁸⁹,Ghoreschi K.⁶^ORCID,Sabat R.¹¹⁰^ORCID

Affiliation:

1. Psoriasis Research and Treatment Centre Charité – Universitätsmedizin Berlin Berlin Germany

2. Inflammation and Regeneration of Skin BIH Center for Regenerative Therapies Charité – Universitätsmedizin Berlin Berlin Germany

3. University of PotsdamInstitute of Nutritional ScienceDepartment of Food Chemistry Potsdam Germany

4. Data and Data Sciences Sanofi‐Aventis Deutschland GmbH FrankfurtGermany

5. Immunology and Inflammation Research Sanofi‐Aventis Deutschland GmbH Frankfurt Germany

6. Department of Dermatology, Venereology and Allergology Charité – Universitätsmedizin Berlin Germany

7. Transcriptome and Genome Core Unit University Medical Center Göttingen Göttingen Germany

8. BIH Center for Regenerative Therapies Charité – Universitätsmedizin Berlin Berlin Germany

9. Institute of Medical Immunology Charité – Universitätsmedizin Berlin Germany

10. Interdisciplinary group Molecular Immunopathology Dermatology/Medical Immunology Charité – Universitätsmedizin Berlin Berlin Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19795

Reference72 articles.

1. Hidradenitis suppurativa

2. Population‐based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa

3. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study

4. Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa

5. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eosinophils in hidradenitis suppurativa patients exhibit pro‐inflammatory traits, implicating a potential pathogenic role in the disease;Experimental Dermatology;2024-07

2. Patient-reported assessment of medical care for chronic inflammatory skin diseases: an enterprise-based survey;Frontiers in Medicine;2024-04-18

3. Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments;NAGOYA J MED SCI;2024

4. S2k-Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa (ICD-10-Code: L73.2);Aktuelle Dermatologie;2024-02

5. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases;Journal of Investigative Dermatology;2024-02